Abstract: A method of making an internal nasal apparatus (10) configured to retain and deliver a quantity of compound within the nose of a user over a minimum period.

Abstract: A body-insertable apparatus which can make the volume smaller by simplifying a mechanism taking in or throwing out predetermined fluid is realized. The body-insertable apparatus has a configuration having, in a housing, a balloon member, a communication adjusting mechanism, a control circuit, and a power source part and forms a storage chamber by the balloon member and an outer circumferential member (sheet holding substrate and part of the housing) covering the outer surface of the balloon member. In the body-insertable apparatus, a first communication pipe communicated with the inner space of the balloon member and a second communication pipe communicated with the outer space are formed. The communication adjusting mechanism communicates the first communication pipe with the second communication pipe based on an electric current output from the control circuit. The inner space of the balloon member is communicated with the outside of the body-insertable apparatus.

Abstract: An improved method, device and formulation for the treatment of nail disorders characterized by de-lamination, thickening or crumbling of the nails. The invention consists of a tubular proboscis (12) attached to a reservoir (13) filled with fluid biocide or cleaning agent that can be inserted under the nail (15) and into the nail cavity (10) and that fluid is forcibly flushed (14) via the proboscis, under the nail, removing contamination (24) and applying a biocide to kill remaining infectious agents (24). The method also includes the use of a specifically designed brush (23) to aid in the removal of built-up carotin waste (11) that manifests as nail thickening and causes cavity formation. The advantages of the invention are that it allows the biocide access the infected area and allows cleaning of the cavity which facilitates re-growth of the nail to the bed.

Abstract: A patient ventilating (23) and aspirating system (8) is disclosed that has a suction tube (9) and connector (6) for connecting to a catheter mount that has a scaled passageway (15). The catheter mount passageway (15) is sealed with an elastomeric seal (16) including a perforation or slit (17). A connector (12) with a piercing member is associated with the suction tube (9). When the connector is attached to the catheter mount the piercing member (20) pierces the seal (16) such that the suction tube (9) can pass through the connector (6) and catheter mount.

Abstract: A pseudo-plastic or thixotropic carrier having anti-malodorous components dissolved or suspended therein is sprayed on the internal surfaces of an ostomy bag or pouch. The viscoelastic properties of the carrier allow the composition to be conveniently dispensed from a spray bottle into the ostomy bag and retained on the inner walls thereof without being displaced therefrom by incoming waste during use of the ostomy bag. This allows the composition to continue to deodorize the ostomy bag headspace even after waste material begins to fill the bag.

Abstract: The invention provides a composition comprising (i) chitosan, a salt or derivative thereof or a salt of a derivative thereof, (ii) a polyol-phosphate or sugar-phosphate salt, (iii) a plasticizer, and (iv) a therapeutic agent. Typically, the composition is a solution or suspension at ambient temperature but forms a gel at physiological temperatures.

Abstract: Embodiments of the invention are directed to methods and systems associated with a disposable dispenser (100, 200) of therapeutic fluid. Preferred embodiments having a small size of less than about 75 mm in length, less than 50 mm in width and less than about 10 mm in thickness and may be releasably attached to the body (B). In one embodiments, the dispenser draws fluid from a flexible volume-conformable reservoir (4) and operates a dosing and metering pump (6, 61, 62, 63) incorporating a motor to deliver fluid through a fluid delivery tool (8, 81, 82). Disposed on the housing bottom (2B) is a peel-of-tape (22) that when removed, electrically connects a power supply (18) to power the operative components (3) of the dispenser into operation, exposes an adhesive (28) and a window (21) opened in the housing (2), and allows the fluid delivery tool (8) to extend for insertion into the skin (S).

Abstract: Disclosed is a method and system of controlling data information between two portable handheld apparatuses where the portable apparatuses include a first apparatus for performing a first operation and a second operation, and a second apparatus including a drug administration device.

Abstract: Methods, devices, kits and compositions to treat a myocardial infarction. In one embodiment, the method includes the prevention of remodeling of the infarct zone of the ventricle. In other embodiments, the method includes the introduction of structural reinforcing agents such as those agents containing aloe-derived pectin. In other embodiments, the structural reinforcing agent may be accompanied by other therapeutic agents. These agents may include, but are not, limited to pro-fibroblastic and angiogenic agents.

Abstract: The invention provides a polymeric film-forming medical sealant. The medical sealant is useful for application to the tonsils and adenoids, wherein the sealant performs at least one of the following functions, a) inhibit the colonization of bacteria, b) inhibit the binding of bacteria to tissue, c) reduction of tissue morbidity, d) hemostasis, e) coating and protection of tissue during healing. e) promotion of healing, and f) reduction of pain.

Abstract: Methods and apparatus for medical treating prostatic tissues are provided. In one embodiment, the method includes removing prostatic tissues adjacent the urethra and enlarging the lumen of the urethra, whereby the treatment conserves a natural wall of the urethra.

Abstract: Methods and devices are provided for manipulating tissue and creating a space in a body cavity. In an exemplary embodiment, a space-creating frame can be delivered and deployed within a body cavity, a cable can be manipulated to tent a tissue wall of the body cavity, and an illumination source and an imaging apparatus can be activated to provide visibility within the body cavity.

Abstract: A syringe assembly for use with an infusion pump having a drive piston. The syringe assembly comprises a substantially hollow syringe housing and a plunger axially movable within the syringe housing to dispense a fluid therefrom. The plunger has a body with a portion thereof configured to engage a radially elastic member associated with the drive piston such that the plunger is releasably axially secured relative to the drive piston.

Abstract: A locking-stressing-mechanism with spring-actuated output drive and a counter with which an apparatus of this kind is fitted, accommodated in a two part housing the two parts of which are mounted to be rotatable relative to each other, can be blocked by means of a pre-stressed leaf spring. The leaf spring is initially accommodated in a recess in the wall of one housing part. As soon as the permitted number of actuations has been reached a push rod pushes the leaf spring out of its resting position. The leaf spring then jumps into a recess in the wall of the other housing part and the two housing parts can no longer be rotated relative to each other. The push rod may be mounted on the pointer of the counter. This blocking device can only be overcome by the application of a force which is sufficient to destroy the device. The device is suitable for blocking a high pressure atomiser or a needleless injector with which a fluid is atomised to form an aerosol or a fluid is injected into a biological tissue.

Abstract: A nucleic acid construct comprising a chimeric promoter sequence and a cloning site for insertion of a coding sequence in operable linkage with the chimeric promoter, wherein the chimeric promoter sequence comprises: (a) a hCMV immediate early promoter sequence; (b) exon 1 and at least a part of exon 2 of the hCMV major immediate early gene; and (c) a heterologous intron provided in place of the intron A region of the hCMV major immediate early gene.

Abstract: An applicator for introducing a therapeutic substance into a body cavity of a subject in need of the therapeutic substance is provided. The applicator has the look and feel of a conventional tampon applicator but delivers a therapeutic substance. Generally, the applicator has a first outer member having a shape suitable for insertion into a body cavity of a mammal and has a dispensing end and a second end distal to the dispensing end. A second inner member is coaxially and slidably housed within the first member such that one end of the second inner member is within the first member. The applicator of the present invention also has at least one aperture located in a side wall of the outer member. The aperture is located on the side wall of the outer member between the dispensing end and the second end of the outer member.

Abstract: The present application is directed to systems and methods associated with infusion pumps, which can optionally utilize an electrokinetic driving mechanism. Infusion pumps, including electrokinetically-driven pumps, are discussed, along with schemes for controlling their operation. As well, systems and methods of detecting malfunctions in infusion pumps are discussed. Any number of malfunctions can be detected including the presence of occlusions and/or leaks. In some instances, a measurement associated with some aspect of electrokinetic phenomena (e.g., an electrode measurement such as voltage or current) is compared with one or more sample values, the comparison allowing an indication of pump malfunction to be determined. A variety of such measurements and comparison techniques are discussed in the present disclosure.

Abstract: An implantable device including conjugate formed of an acrylamide-based copolymer and a bioactive agent is provided.

Abstract: The present invention provides novel HSP20-based polypeptides and pharmaceutical compositions thereof, and methods for using such polypeptides and pharmaceutical compositions for various therapeutic uses.

Abstract: Device designed for regenerating the human dermis presented in the form of a multilayer complex combining an absorbable polymeric internal matrix able to induce the regeneration of the dermis by contact with muscle or subcutaneous tissue, an open-work textile mesh and a transparent external support wherein the open-work textile mesh is contained in the body of the transparent support.

Abstract: Medicinal applicator suitable for delivering medicinal material in a measured dose and concentration to a body cavity, having an elongate support body with an external surface and a blunt distal end to facilitate insertion into a body cavity and a support element receiving zone located towards the distal end for receiving the support element. The support element receiving zone is configured to receive a correspondingly shaped support element for carrying medicinal material, whereby upon insertion of the elongate body into the body cavity, medicinal material supported on the support element located in the receiving zone is released to a desired location within the cavity.

Abstract: A method for managing at least one breathing condition may include storing an agent near a patient's airway and delivering the agent to the mucosal tissue in the pharyngeal area in a time-released manner during a sleep period. The delivered agent may cause increased contraction of muscle tissue in the pharyngeal area.

Abstract: The needle head assembly is used with an ISO luer lock or luer slip syringe having a single thread or multiple threads. The assembly includes a one or two piece luer needle housing having a plunger end, a needle end and a pair of opposing slots located at the needle end thereof. A plunger is axially movable relative to the upper end of the luer needle housing. A needle holder assembly is located in the needle end of the needle housing, with the holder assembly including a bridge fixed in the needle end of the needle housing. The bridge includes a needle holder that has portions extending in opposite directions from the bridge. A diaphragm with a center aperture is sleeved over one of the portions of said needle holder which faces the plunger end of the needle housing. The needle holder has a center passage which permits a needle to be inserted and secured in position at the time of assembly.

Abstract: A suppository for use in an anal canal has a shaft and ring positioned on the shaft between the first end and the second end of the shaft. The ring extends outwardly of the shaft and has a diameter of between 8 and 14 millimeters. The ring has a generally toroidal shape. The shaft and the ring are preferably integrally formed together. The diameter of the shaft is, preferably, between ? and ? of a maximum diameter of the ring.

Abstract: The exemplary embodiment of the present invention would provide an apparatus for concealed transport of a medical fluid administration device. The medical fluid administration device would be capable of infusing medical fluids to, or collecting medical fluids from, as the case may be, the body of a patient during concealed transport. The exemplary apparatus would comprise one or more of the following: a stand disposed within a carrying case, said stand capable of being extended during stationary use or collapsed during ambulatory use; a medical fluid pump disposed within the carrying case, said pump capable of delivering or collecting medical fluids during concealed transport within the carrying case; and a tubing retraction device for engaging tubing for delivery of medical fluids to, or collection of medical fluids from, a body of a patient.

Abstract: This invention relates to a biomaterial comprising an injectable bioresorbable polysaccharide composition wherein the polysaccharide may be succinochitosan glutamate. This invention also relates to a biomaterial comprising an injectable bioresorbable polysaccharide composition in which resorbable particles may be in suspension, the said particles comprising or consisting essentially of chitin and/or chitosan, which may be free of any additional formulation modifying agents, and a process for manufacturing the same. This invention also relates to a medical device including said biomaterial and to a method of repair or treatment including the filling of cavities in the human face or body.

Abstract: A solid drug perforator (SSP) system and an associated drug reservoir are provided for delivering theraputic, prophylactic and/or cosmetic compounds, for nutrient delivery and for drug targeting. For drug delivery, the SSP system includes an active drug ingredient and a matrix of perforator material that biodegrades or dissolves quickly upon contact with a patient's body. The SSP system provides a skin barrier perforator and a controller for prompt initiation and cut-off of drug delivery. In a preferred method of transdermal drug delivery, an SSP system containing a selected drug penetrates into an epidermis or dermis, and the drug is promptly released from the (dissolving) SSP system perforator. An additional drug is optionally delivered from a patch reservoir through skin pores created by insertion of the perforator. Formulation and fabrication procedures for the SSP and associated reservoir are also provided. An SSP system can be fabricated with variety of shapes and dimensions.

Abstract: This invention relates to apparatus and methods of delivering various compositions including medicaments to a variety of targets. The invention includes a dose administrator (1) which may be used for intranasal delivery of compositions or medicaments, such as live virus vaccines, to both humans and animals. An axial collapse prevention element (2) to prevent excessive axial deflection of the dose administrator (1) or a dose-location coordinate indicator (3) to facilitate the delivery of a dose to the desired target location may be coupled to the dose administrator (1). An intranasal probe (4) having a force dissemination contact surface (7) may be responsive to a first end of the dose administrator (1). The dose may be delivered from a conformable dose sequestration element (10) through an aperture which penetrates the dose delivery aperture element (5) and the dose may be caused to stream by coupling a stream delivery element (6) to the dose delivery aperture element (5).

Abstract: Stabilizing an object in the body of a patient involves the injection of a lower critical solution temperature (LCST) material or other flowable material into the body of the patient so that the material contacts the object. The LCST material or other flowable material then forms a gel in the body such that the object is contained at least partially within the gel and thereby stabilized by the gel such that the object can then be easily fragmented within the body and/or retrieved from the body.

Abstract: A method and device are described for applying a microprotrusion member (44) including a plurality of microprotrusions (90) to the stratum corneum with impact. The method and device are used to improve transport of an agent across the skin for agent delivery or sampling. The applicator (10, 60, 80) causes the microprotrusion member (44) to impact the stratum corneum with a certain amount of impact determined to effectively pierce the skin with the microprotrusions (90). The preferred applicator (10, 60, 80) impacts the stratum corneum with the microprotrusion member (44) with an impact of at least 0.05 joules per cm2 of the microprotrusion member (44) in 10 msec or less.

Abstract: A flow control device includes a sealing component that can be positioned within a bronchial lumen. The sealing component can comprise two or more overlapping segments that are movable relative to one another such that the segments collectively form a seal that can expand and contract in size to fit within and seal bronchial lumens of various sizes.

Abstract: The present invention provides a catheter for the delivery of fluid medication across an anatomical region. In accordance with one embodiment, the catheter comprises an elongated tube with a plurality of exit holes along an infusion section of the catheter, and an elongated flexible porous member residing within the tube and forming an annular space between the tube and the member. In accordance with other embodiments, the catheter includes a tube having a plurality of exit holes in a side wall of the tube. The exit holes may combine to form a flow-restricting orifice of the catheter. Advantageously, fluid within the catheter flows through all of the exit holes, resulting in uniform distribution of fluid within an anatomical region. In one particular embodiment, the catheter comprises a tube having elongated exit slots therein. In accordance with other embodiments, the catheter includes an elongated tubular member made of a porous membrane.

Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.

Abstract: A method and apparatus for readily and reliably screening olfactory mucosa stimulating compounds are provided. An olfactory mucosa stimulating compound is sprayed through an atomizing nozzle 33 to an olfactory mucosa of a rat fixed in a test animal fixing device 32. A measuring electrode portion 10 is implanted in an olfactory bulb of the rat for measuring an electrical signal generated in the olfactory bulb. Efficacy of the olfactory mucosa stimulating compound is determined based on a correlation between an electrical signal measured by the measuring electrode portion 10 when the olfactory mucosa stimulating compound is sprayed on the olfactory mucosa of the rat and a physiological response induced in the rat.

Abstract: The invention provides a variety of surgical instruments for forming a liquid jet, which are useful for performing a wide variety of surgical procedures. In some embodiments, the invention provides surgical liquid jet instruments having a pressure lumen and an evacuation lumen, where the pressure lumen includes at least one nozzle for forming a liquid jet and where the evacuation lumen includes a jet-receiving opening for receiving the liquid jet when the instrument is in operation. In some embodiments, the pressure lumen and the evacuation lumen of the surgical liquid jet instruments are constructed and positionable relative to each other so that the liquid comprising the liquid jet, and any tissue or material entrained by the liquid jet can be evacuated through the evacuation lumen without the need for an external source of suction.

Abstract: A hydrogel forming system which comprises a hydrophobic macromer with unsaturated group terminated ends and a hydrophilic polymer which is a polysaccharide (e.g. dextran) containing hydroxy groups which are reacted with unsaturated group introducing compound, is convertible by free radical polymerization to form a hydrogel containing a three dimensional crosslinked polymer network containing hydrophobic and hydrophilic components. Agent can be entrapped in the polymer network, e.g., drugs, macromolecules or synthetic or natural polymers, for controlled release therefrom.

Abstract: The invention relates to a needleless syringe (1), comprising the following' successively: a gas generator, a gas expansion chamber (3), a means for retaining particles of the active agent and a tube (6) for ejecting said particles. The main characteristic of the inventive syringe is that the gas generator is a pyrotechnic generator (2), comprising a pyrotechnic charge (10) which generates gas, a gas generator and an initiation device. The invention is also characterized in that the retaining means comprise at least one lid (8), which is fixed to the ejection tube and is configured to break under the influence of the gases generated by the combustion of said charge (10).

Abstract: A hydrogel forming system which comprises a hydrophobic macromer with unsaturated group terminated ends and a hydrophilic polymer which is a polysaccharide containing hydroxy groups which are reacted with unsaturated group introducing compound, is convertible by free radical polymerization to form a hydrogel containing a three dimensional crosslinked polymer network containing hydrophobic and hydrophilic components. Agent can be entrapped in the polymer network, e.g., drugs, macromolecules or synthetic or natural polymers, for controlled release therefrom. In one embodiment, a vascular stent is coated with hydrogel with therapeutic agent entrapped therein.

Abstract: Devices formed of or including biocompatible polyhydroxyalkanoates are provided with controlled degradation rates, preferably less than one year under physiological conditions. Preferred devices include sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone filling augmentation material), adhesion barriers, stents, guided tissue repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes, bone graft substitutes, bone dowels, wound dressings, and hemostats.

Abstract: The invention relates to a pharmaceutical composition comprising Factor VIIa for subcutan, intramuscular or interdermal administration. Factor VIIa administered subcutanously, intramuscularly or intradermally shows a sufficient transport into the bloodstream in biologically active form and in adequate concentrations, and favorable pharmacokinetic properties.

Abstract: An apparatus to make a certain volume of liquid available for atomization comprises a container adapted to hold a liquid, and a piston pump. The piston pump comprises a piston member and a valve body, with the piston member being slidable within the valve body. Further, the valve body functions with the piston member to define a metering chamber. In this way, the metering chamber is adapted to be filled with liquid from the container when the piston member is moved to a filling position, and the piston pump is adapted to dispense a known volume of the liquid from the metering chamber when the piston member is moved to a dispensing position.

Abstract: Materials, devices and methods for the treatment of congestive heart failure are disclosed. In these methods, the volume of the left ventricle is reduced, thereby increasing the efficiency of the pumping action of the heart. Volume reduction is accomplished by introduction of biocompatible materials into the wall of the left ventricle, or into the ventricle itself. Suitable biocompatible materials include those that undergo a phase transition within the ventricle or within the wall of the ventricle, and are thereby converted from a substantially liquid state to a substantially solid state. Such materials also include those which increase in volume during the transition from the liquid state to the solid state. Also disclosed is a method for ventricular geometry reduction wherein flexible, elastic bands are attached to the external surface of the heart to effect a decrease in the volume of the left ventricle.

Abstract: The present invention comprises the connection tube (10), having a basal end portion connected with the waste matter sucking tube (44) communicating with the waster matter tank provided with the sucking pump (30), and a jet nozzle (19) for jetting the rinsing water, having a basal end portion connected with a rinsing water tube 30 communicating with a rinsing water tank (33) provided with a compressor (31), and characterized by that the connection tube (10) and the jet nozzle (19) are installed with their respective end portions are installed orienting the same directions, so that the operation for changing the types of the rostral sucking nozzle 12 or the repetitive alternate operation for the jetting of the rinsing liquid and the operation for the drawing of the waste water resulting from the rinsing operation or the simultaneous operation for the both can be simplified.

Abstract: Methods and devices for reducing the mineral content of a region of non-intimal vascular tissue are provided. In the subject methods, an isolated local environment that includes the region to be demineralized is produced. The pH of the local environment is then reduced to a subphysiologic level, e.g. by flushing with an acidic dissolution fluid, for a period of time sufficient for the mineral content of the region to be reduced. The devices of the subject invention are characterized by comprising a means for producing an isolated local environment that includes a non-intimal region of vascular tissue. Also provided are kits for practicing the subject methods.

Abstract: A device and method for treating an illness or infection in the repiratory tract of a body is provided. The device administers an antimicrobial mist directly to the tissues to be treated, which coats the tissues in the respiratory tract where the infection is colonizing. The administration of the mist is reapplied in order to maintain a predetermined antimicrobial tissue density concentration of a uncompounded silver colloid suspended antimicrobial substance for a predetermined time period.

Abstract: A medical device known as a catheter is configured with a variable infusion rate to deliver a therapeutic substance such as pharmaceutical compositions, genetic materials, and biologics to treat a variety of medical conditions such as pain, spastisity, cancer, and other diseases in humans and other animals. The variable infusion rate catheter provides clinician with increased flexibility, versatility, and many other improvements. The variable infusion rate catheter has a Micro Electro Mechanical System (MEMS) flow restriction with a variable infusion rate. The MEMS flow restriction is fluidly coupled to the catheter to receive therapeutic substance dispensed from a therapeutic substance delivery device and restrict the therapeutic substance flow to a desired infusion rate. Many embodiments of the variable infusion rate catheter and its methods of operation are possible.

Abstract: A parenteral apparatus (10, 50, 60, 70, 90, 110, 120) comprises a chamber (26) for parenteral fluid within a housing (12). The apparatus also includes an axially slidable seal (24) operatively associated with a needle (28) and a catheter (32) enclosing the needle (28) in part. In operation, the needle (28) makes an incision in tissue by means of a sharp point (33) and it is then withdrawn into the housing (12) whilst the catheter remains in contact with the tissue. The parenteral fluid is expelled by movement of the seal (24) from the chamber (26) through the needle (28) initially and subsequently through the needle (28) and the catheter (32) as the needle (28) is withdrawn.

Abstract: An ear canal dryer that removes excess fluid or moisture retained in the outer ear canal. The ear canal dryer comprises a bulb and a speculum, each having an air flow controller. By inserting the speculum into the ear canal and squeezing the bulb, an air stream is injected into the ear canal causing evaporation of fluid and carrying the moisture out of the canal. The ear canal dryer of the present invention is easy to carry and use. It can be manufactured at a low cost and may also be adapted for veterinary use.

Abstract: Methods and apparatus are disclosed for treating body tissue whereby a section of tissue is drawn into contact with the open distal end of the first passageway of the apparatus. A tissue treatment fluid is introduced into the second passageway for treating the desired section of tissue retained within the first passageway. Methods and apparatus are also disclosed for positioning a medical device at a desired location within the heart. A portion of the apparatus is retained at a desired location of the heart and a medical device is extended through a passageway of the apparatus for contacting the heart at the desired location.

Abstract: A method and packaging for vaccinating or medicating an animal by implanting a solid dose medicament in an animal. The solid dose medicament, or plurality of such medicaments, are each color-coded to identify a particular active ingredient, then packaged in a pellet magazine through which the doses are visible, and thereafter the pellets are implanted, usually subcutaneously, into the base of the ear or in the neck of an animal. The same system can be used for colored ballistic implants.